It’s the data people. Focus in on the performance of Leronlimab itself. It is zipping thru clinical trials . Was in Pharma for a long time and it may look like a slow process to many, but I can assure you this drug went from not being involved in Covid at all in the beginning of the year to being in a phase 3 trial in the summer. And its performing. The media is a distraction